Futureceuticals is home to a host of functional ingredients that you will have likely come across at some capacity when buying sports nutrition products, especially when we rattle off their names. Futureceuticals is the company behind elevATP, the superfood blends S7, Spectra, PhytoServ, and TruServ, the nootropic CognatiQ, previously NeuroFactor, the recovery-powerhouse VitaCherry Sport, and the ingredient we’ve got the spotlight specifically on today, the joint health supporting Promentum.
Promentum, a patented boro-carbohydrate from Futureceuticals, delivers bioactive and bioavailable boron as calcium fructoborate. The plant-identical molecule supports joint health, mobility, bone strength, nutrient utilization, and hormone balance. Two decades of clinical research show Promentum’s fast-acting nature, with significant improvements in joint comfort and flexibility within one week. These benefits strengthen over 90 days, providing noticeable bioactivity that consumers can feel.
Futureceuticals Promentum has a unique structure that allows optimal absorption and utilization by the body, boosting the activity of calcium, magnesium, and vitamin D. The versatile benefits of the innovation make it ideal for various supplement categories, such as dedicated joint health as well as comprehensive recovery types like post-workout and aminos. Promentum also has approvals from regulatory bodies in most of the major markets, including Europe, Australia, and beginning this past month, Canada, as Health Canada has issued approval on claims and dosing.
Promentum has been in the Futurecauticals family for several years, and in a category of health and nutrition that doesn’t get as much attention as others, the ingredient house plays in; it’s great to see the effort going into it. The development of Promentum gaining claim and dosage approval in Canada is a big deal, as international use can be the difference between a supplement company using an ingredient that works in all regions versus one that doesn’t, forcing the expensive path of separate production runs.
